Tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor binding protein-7 (IGFBP7) both act to block the G1 stage of the renal tubular epithelial cell cycle during AKI [8–11]. Here, IGFBP7 is linked to acute kidney injury.